Stocks and Investing Stocks and Investing
Tue, June 6, 2023
Mon, June 5, 2023

Raghuram Selvaraju Reiterated (AQST) at Strong Buy and Held Target at $5 on, Jun 5th, 2023


Published on 2024-10-28 04:12:42 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aquestive Therapeutics, Inc." (AQST) at Strong Buy and Held Target at $5 on, Jun 5th, 2023.

Raghuram has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Andreas Argyrides of "Wedbush" Upgraded from Hold to Buy and Increased Target to $4 on, Thursday, March 9th, 2023
Contributing Sources